ICON Clinical Research Ltd

62 Forest Street, Suite 300, Marlborough, MA 01752

Public
Healthcare & Pharmaceuticals - Biotechnology
over $1B
over 10K
+353.1.291.2000


ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full service solution. We are also an end-to-end Pharmacovigilance service provider and this includes Post Marketing Surveillance activities too. ... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with ICON Clinical Research Ltd?




374 Contacts at this company
Dawn Flook
Director of Production Services
Michael Tokar MS, PMP
Director of Project Management ...
Greg Zak
Portfolio Lead, Sr. Director Business ...
Mike Fedock
Chief Financial Officer
Deepa August
Clinical Research Associate
Doreen Tokazewski
Sr. Project Manager
Jennifer Vineyard
Director, Clinical Operations ...
Dr. Eric Goldberg
Senior Medical Director
Kelly Murphy
Director, Partner Relations

Jul 25, 2018 17:49:36
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development [...]

Jul 25, 2018 17:31:19
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development [...]

Jun 27, 2018 17:30:41
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology [...]

Jun 27, 2018 17:06:18
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology [...]

Jun 11, 2018 17:30:32
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a global provider of drug development and  [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.